Introduction
============

*Staphylococcus aureus* and *Staphylococcus epidermidis* are common commensals of human skin and the nares and are highly proficient at forming biofilms. Both species are significant causes of nosocomial infections associated with indwelling medical devices ([@B48]). It is now widely acknowledged that many of the antimicrobial resistance genes identified in clinical isolates of *S. aureus* were acquired from coagulase negative staphylococci (CoNS) such as *S. epidermidis* by transfer of mobile genetic elements (MGEs) ([@B36]). One very significant example of this is the horizontal acquisition by *S. aureus* of staphylococcal cassette chromosome-*mec* (SCC*mec*) elements harboring the methicillin resistance gene *mec* from *S. epidermidis*. To date, 13 different types of SCC*mec* (I-XIII) have been characterized in methicillin-resistant *S. aureus* (MRSA)^[1](#fn01){ref-type="fn"}^ differentiated according to the various combinations of *mec* and cassette chromosome recombinase (*ccr*) gene complexes present ([@B20]; [@B55]; [@B2]). Many more SCC*mec* variants have been described in species in which methicillin-resistance (MR) is more common, such as *S. epidermidis* (MRSE) and other CoNS ([@B45]).

The staphylococcal arginine catabolic mobile element (ACME) plays a role in colonization of human skin and evasion of host immune responses ([@B10]; [@B38]). It is considered an SCC-like element as, like SCC*mec*, it is flanked by homologous inverted and direct repeat sequences (DRs) that integrate into the same *attB* attachment site in the chromosomal *orfX* locus as SCC*mec* ([@B21]; [@B9]). Specific clonal lineages of *S. aureus* are known to harbor ACME, most notably the highly successful USA300 clone, which harbors a composite island (CI) composed of SCC*mec* type IVa and ACME type I ([@B9]). The prevalence of ACME has also been reported to be high in sequence type (ST) 239 MRSA isolates (43.7%) from screening swabs of hospitalized patients in Singapore ([@B19]) and in ST239-like (as determined by pulsed-field gel electrophoresis) bloodstream MRSA isolates (39%) recovered in Australia ([@B13]).

Like SCC*mec*, ACME is more prevalent and exhibits greater diversity in *S. epidermidis*. Many studies have identified ACME in multiple STs of the predominant *S. epidermidis* clonal lineages based on multilocus sequence typing (MLST), suggesting that ACME originated in this species ([@B29]; [@B3]; [@B35]). To date, ACME has been detected in the range of 45.8--67.9% in *S. epidermidis* isolates recovered from disparate geographical locations, as well as in carriage and disease isolates ([@B9]; [@B29]; [@B3]; [@B35]).

The ACME genetic island ranges between 30 and 55 kb in size and is associated with three main gene clusters, the *arc* operon composed of the *arcR/A/D/B/C* genes, the *opp3* operon composed of the *opp3A/B/C/D/E* genes, and the recently revealed *kdp* operon, composed of the *kdpE/D/A/B/C* genes ([@B9]; [@B33]). These gene clusters encode an arginine deaminase pathway, an oligopeptide permease ABC transporter and a potassium ABC transporter, respectively. These three operons which can be present in ACME are in addition to the native chromosomal *arc*, *opp1* and *opp2*, and *kdp* operons in *S. aureus* ([@B10]; [@B56]; [@B39]).

Five distinct ACME types have been described to date, according to the presence of the *arc* and *opp3* operons (type I), the *arc* operon only (type II), the *opp3* operon only (type III), the *arc* and *kdp* operons (type IV), and all three *arc*, *opp* and *kdp* operons (type V) ([@B16]; [@B9]; [@B46]; [@B28]; [@B33]). Furthermore, two distinct ACME IV subtypes, IVa and IVb have been described based on distinct combinations of flanking DRs ([@B33]). To date, all five types and several variants thereof have been described in *S. epidermidis* ([@B29]; [@B3]; [@B35]; [@B49]; [@B28]; [@B33]). In contrast, types I and II and variants thereof have been detected in *S. aureus*, commonly collocated with other genetic elements such as SCC*mec* or SCC-associated genes in CIs and separated from these adjacent elements by DRs ([@B9]; [@B46]; [@B22]; [@B42]).

Although staphylococci are considered transient members of the oral microflora, these species are prevalent in the oral cavities of the elderly and in people with dental infections such as periodontal disease ([@B31]; [@B14]). Periodontal disease is an inflammatory condition that can progress from gingivitis in response to dental plaque and affects the gingiva as well as the supporting periodontal structures ([@B17]). As periodontal disease progresses, enlargement of the gingival crevice occurs and leads to eventual detachment of the gingival tissue from the tooth resulting in periodontal pocket formation. Periodontal pockets provide a semi-anaerobic nutrient-poor environment that is ideal for plaque accumulation by resident oral microflora and is prone to decreases in pH resulting from physiological processes such as tissue repair ([@B37]).

The titanium-based oral implant can act as an ideal substrate for staphylococcal-based biofilm formation ([@B53]), as can the oxygen-depleted environment of periodontal and peri-implantitis pockets. Dental implants are indwelling medical devices made of titanium-based alloys that are placed in the bone of the mandible or maxilla to anchor a prosthetic crown, denture or bridge ([@B1]; [@B5]). They consist of a shaft that is placed directly in the jaw bone and stabilized by subsequent osseointegration, and an abutment onto which a prosthesis is fitted. Similar to gingivitis, peri-implant mucositis is an inflammatory condition that affects the gingivae surrounding a dental implant, which can progress to peri-implantitis in which supporting bone surrounding an implant is gradually lost, potentially resulting in implant failure ([@B41]).

Both of these oral diseases have a similar etiology in that they are both associated with dental plaque in which a shift from normal resident microflora to more periodontopathogenic species appears to occur ([@B32]).

This study investigated the prevalence of *S. epidermidis* and *S. aureus* in the oral cavities, subgingival sites and periodontal pockets of patients with implants and natural teeth in states of both health and disease. Isolates recovered were investigated for ACME to determine if ACME could be a molecular marker for periodontal disease and/or peri-implantitis. Previous studies investigated the prevalence of ACME in both *S. aureus* and *S. epidermidis* in a range of carriage and infection sites ([@B29]; [@B3]; [@B12]; [@B35]), however, to our knowledge, no studies have investigated the prevalence of ACME among oral staphylococcal isolates from periodontal pockets or peri-implantitis sites. A selection of the ACME-positive isolates identified in the present study were further investigated by whole-genome sequencing (WGS) in order to elucidate the genetic organization of the ACMEs in detail. Such investigations could yield important information regarding the potential genetic reservoir of ACME that exist among *S. epidermidis* for potential future spread to MRSA.

Materials and Methods {#s1}
=====================

Study Group
-----------

Ethical approval for this study was granted by the St. James's Hospital and Federated Dublin Voluntary Hospitals Joint Research Ethics Committee (JREC) and the Faculty of Health Sciences Ethics Committee of Trinity College Dublin, Ireland. Prior to enrollment in the study, all participants were provided with comprehensive patient information documentation and all participants included provided written consent. All documentation (including consent forms) provided to patients was pre-approved by the Research Ethics Committees.

All participants in the study met the following criteria: they were over 18 years of age, had a minimum of 10 natural teeth and were capable of providing informed consent. Participants were excluded from the study if they had any of the following factors: diabetes or asthma, pregnancy or lactation, blood-borne illnesses, steroid treatment within the year or antibiotics within 2 months prior to sampling. Patients with periodontal disease had a minimum of one periodontal site with a probing depth of greater than 6 mm and bleeding on probing (BOP). Patients with peri-implantitis were partially dentate and had one or more oral implants in place for a minimum of 5 years, at least one of which showed clinical signs of disease ([@B44]; [@B18]). The study group consisted of 31 orally healthy patients with dental implants, 20 patients with periodontal disease, 21 patients with peri-implantitis and 64 orally healthy participants.

Sample Collection and Processing
--------------------------------

All clinical sampling was carried out by qualified Dentists at the Dublin Dental University Hospital (DDUH). Sub-gingival sites and periodontal pockets were sampled by inserting a PerioPaper^TM^ gingival fluid collection strip (Oroflow, Plainview, NY, United States) into the sub-gingival crevice or periodontal pocket for 30 s. Following sampling the collection strips were placed in sterile 2 ml screw-capped tubes (Sarstedt AG & Co., Numbrecht, Germany) containing 1 ml of nutrient broth (NB) (Oxoid Ltd., Hampshire, United Kingdom). In addition, oral rinse samples were collected by providing participants with sterile 100 ml plastic cups (Sarstedt AG & Co.) containing 25 ml sterile phosphate buffered saline (PBS) and instructing the participant to rinse their mouths with the PBS for 30 s before returning the rinse fluid to the same container. The anterior nares of participants were sampled using nitrogen-gassed VI-packed sterile transport swabs (Sarstedt AG & Co.). Following sampling, all samples were transported immediately to the microbiology laboratory and processed within 4 h. Vials containing PerioPaper^TM^ strips suspended in NB were vortexed at maximum speed for 1 min and 100 μl aliquots of the resulting cell suspension were plated onto mannitol salt agar (MSA) and Sa*Select*^TM^ chromogenic agar (Bio-Rad Laboratories, Hertfordshire, United Kingdom) agar. Oral rinse samples were processed by transferring a 1 ml aliquot to a sterile 1.5 ml Eppendorf Safe-lock^TM^ microfuge tube (Eppendorf, Hamburg, Germany) and centrifuged at 20,000 ×*g* for 1 min, after which the supernatant was discarded and the resultant pellet was resuspended in 200 μl NB. To isolate staphylococcal colonies, 100 μl aliquots of this cell suspension were plated on MSA and Sa*Select*^TM^. Nasal swabs were used to lawn the entire surface of MSA and Sa*Select*^TM^ plates. Inoculated MSA and Sa*Select*^TM^ plates were incubated at 37°C for 48 h in a static incubator (Gallenkamp, Leicester, United Kingdom).

Culture, Identification and Storage of Isolates
-----------------------------------------------

Bacterial isolates were cultured on Columbia blood agar (Fannin Ltd., Dublin, Republic of Ireland) at 37°C for 48 h prior to identification by Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry system (MALDI-TOF MS) (Vitek, bioMérieux Marcy l'Etoile, France) according to the manufacturer's instructions. Multiple isolates were identified and stored from each sample for future analysis. All isolates were stored on Microbank^TM^ storage beads (Pro-Lab Diagnostics, Cheshire, United Kingdom) at -80°C.

DNA Isolation and Detection of ACME by Multiplex PCR and DNA Microarray Profiling
---------------------------------------------------------------------------------

Where possible, a minimum of two isolates were selected as representatives of each individual participant, distinct sample sites and each staphylococcal species recovered and screened by multiplex PCR to detect the presence of ACME.

Genomic DNA was extracted from isolates by enzymatic lysis using the buffers and solutions provided with the *S. aureus* Genotyping Kit 2 DNA microarray kit (Alere Technologies GmbH, Jena, Germany) and the DNeasy Blood and Tissue kit (Qiagen, Crawley, West Sussex, United Kingdom) according to the manufacturers' instructions.

The presence of ACME was detected in isolates by multiplex PCR targeting the *arcA, opp3B* and *kdpA* genes harbored by ACME using the previously described *arcA*- and *opp3B*-directed primers ([@B9]; [@B28]) and incorporating primers targeting the *kdpA* gene (kdpF: 5′-CGGTTTAACTGGTGCGTT-3′ and kdpR: 5′-GCAATACATACAGCGTAGCC-3′) ([@B33]). PCR assays were carried out in 50 μl reaction volumes containing a 200 μM concentration of each deoxynucleoside triphosphate, 1.25 U of GoTaq polymerase (Promega, Madison, WI, United States), 10 μl (1×) of GoTaq FlexiBuffer (Promega), 2.5 μM MgCl~2~, 100 pmol of each primer, and 1 ng of the DNA template. Cycling conditions consisted of 94°C for 2 min, followed by 35 cycles of 94°C for 30 s, 60°C for 30 s, 72°C for 45 s and followed by a final elongation step of 72°C for 10 min. Amplification products (*arcA* product: 724 bp, *opp3B* product 530 bp, *kdpA* product: 241 bp) were separated by electrophoresis in 2% (w/v) agarose (Sigma-Aldrich Ltd., Wicklow, Republic of Ireland) containing 1X GelRed^®^ (Biotium Inc., Fremont, CA, United States) and visualized using an Alpha Innotech UV transilluminator (Protein Simple, San Jose, CA, United States).

The presence of *mec* and ACME-*arc* genes amongst *S. aureus* and *S. epidermidis* isolates investigated was also detected by DNA microarray profiling using the *S. aureus* Genotyping Kit 2.0 (Alere Technologies GmbH, Jena, Germany) according to the manufacturer's instructions and as described previously ([@B30]).

Molecular Characterization of ACME Elements by WGS
--------------------------------------------------

A total of 35 *S. epidermidis* isolates selected as representatives of each patient group, sample site and ACME type present were subjected to WGS (**Table [1](#T1){ref-type="table"}**). Libraries were prepared using Nextera XT library preparation reagents (Illumina, Eindhoven, Netherlands) and sequenced using an Illumina MiSeq desktop sequencer. For each isolate, reads were aligned with reference *S. epidermidis* and *S. aureus* genomes containing ACME and/or SCC elements downloaded from Genbank using a Burrows-Wheeler aligner (BWA) ([@B24]) to select the most appropriate reference ACME type to use as a scaffold. *De novo* assemblies were carried out on the reads for each ACME-harboring isolate using SPAdes version 3.6^[2](#fn02){ref-type="fn"}^. For each isolate, the reference genome that exhibited the highest degree of alignment with the relevant reads was used in a further alignment with the annotated contigs from the *de novo* assembly of the relevant isolate. Contigs identified as containing ACME- or SCC*mec*-associated DNA sequences were aligned, annotated and visualized using BioNumerics version 7.6 (Applied Maths, Sint-Martens-Latem, Belgium) and the Artemis sequence viewer ([@B4]).

###### 

Population of *Staphylococcus epidermidis* isolates subjected to whole genome sequencing.

  Isolate                                                   Sample site   Patient   ACME type/subtype   ACME/CI size (kb)   ST^a^   Genbank accession number^b^
  --------------------------------------------------------- ------------- --------- ------------------- ------------------- ------- -----------------------------
  **Participants with periodontal disease (*n* = 12)**                                                                              
  P8OR3                                                     OR            P8        IVb                 54.2                210     MG787414^b^
  P9OR1                                                     OR            P9        IIb                 31.1                701     MH188462
  P9PPH12                                                   SG            P9        IIb                 31.1                73      MH188463
  P9PPHI1                                                   SG            P9        IIb                 31.1                73      MH188464
  P11OR1                                                    OR            P11       IIb                 31.1                73      MH188465
  P11PPH21                                                  SG            P11       IIb                 31.1                73      MH188466
  P11PPP12                                                  PP            P11       IIa                 54.4                59      MH188467
  P14OR1                                                    OR            P14       I                   54.3                17      MH188468
  P14PPP2                                                   PP            P14       IIc                 53.9                672     MH188469
  P14NS2                                                    NS            P14       IIb                 30.7                14      MH188470
  P16OR1                                                    OR            P16       III                 53.9                329     MF346684^b^
  P19PPP1                                                   PP            P19       IIc                 53.5                672     MH188471
  **Participants with peri-implantitis (*n* = 9)**                                                                                  
  PS36PD                                                    SG            PS36      IVa                 40.2                432     MG787422^b^
  PS7OR                                                     OR            PS7       IIb                 32                  73      MH188472
  PS7P2                                                     SG            PS7       IVa                 67.8                153     MH188473
  PS23P1                                                    SG            PS23      IVb                 54.2                153     MH188474
  PS30PH                                                    SG            PS30      IVa                 68.3                153     MG787421^b^
  PS34PI                                                    SG            PS34      IIb                 31.6                14      MH188475
  PS8TI                                                     SG            PS8       IIb                 32                  73      MH188476
  PS19PH                                                    SG            PS19      V                   116.9               5       MG787423^b^
  PS21NS                                                    NS            PS21      IVa                 55.8                297     MG787420^b^
  **Orally healthy participants with implants (*n* = 6)**                                                                           
  I9OR1                                                     OR            I9        IVa                 67.8                153     MG787415^b^
  I11OR1                                                    OR            I11       III                 45.1                329     MF346685^b^
  I12OR1                                                    OR            I12       I                   39.9                7       MH188477
  I14OR1                                                    OR            I14       IVa                 67.8                153     MG787416^b^
  I23OR2                                                    OR            I23       IIb                 48                  89      MH188478
  I1PPP121                                                  SG            I1        III                 66.9                329     MH188479
  **Orally healthy participants (*n* = 9)**                                                                                         
  120PPC                                                    SG            120       IVa                 67.8                153     MG787417^b^
  200OR2                                                    OR            200       IIb                 32                  73      MH188480
  201OR2                                                    OR            201       IIa                 27                  59      MH188481
  204OR1                                                    OR            204       III                 65.6                329     MF346683^b^
  217PPP362                                                 SG            217       IIa                 74.6                59      MH188482
  218PP361                                                  SG            218       IVa                 39                  130     MG787418^b^
  32BR                                                      OR            32        IIb                 32                  73      MH188483
  33BR                                                      OR            33        IVa                 48.8                17      MG787419^b^
                                                                                                                                    

a

The ST of each isolate was determined by uploading the sequence of seven housekeeping genes to the

S. epidermidis

MLST online database (

https://pubmlst.org/sepidermidis/

).

b

The genetic structure of these ACMEs has been described previously (

McManus et al., 2017

;

O'Connor et al., 2018

). ACME, arginine catabolic mobile element; ST, sequence type; OR, oral rinse; PP, periodontal pocket; SG, subgingival site.

In order to confirm the genetic organization and orientation of contigs, primers were designed using BioNumerics version 7.6 that targeted a minimum distance of 200 nucleotides from the contig boundaries. The target specificity of primers was confirmed using BLAST software^[3](#fn03){ref-type="fn"}^. All primers were supplied by Sigma--Aldrich Ltd. Contig gaps were closed based on PCR-based amplification and Sanger-based sequencing of these regions using the primers listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. Sanger-based sequencing was carried out commercially by Source BioScience (Waterford, Republic of Ireland).

Multiple alignments of the complete nucleotide sequences of the *arc*, *opp3* and *kdp* operons (including intragenic regions) from each isolate investigated were carried out using the Clustal Omega tool ([@B47]). The nucleotide sequence from the first to last base of each operon, including any intragenic regions was compared among all isolates investigated in the present study.

Determination of STs Among Isolates Subjected to WGS
----------------------------------------------------

The STs of ACME-harboring *S. epidermidis* isolates subjected to WGS were determined from the WGS data by examination of the nucleotide sequences of the loci used for the consensus *S. epidermidis* MLST scheme ([@B50]). Briefly, the relevant nucleotide sequences were gleaned from the WGS data and inputted into the *S. epidermidis* MLST database online^[4](#fn04){ref-type="fn"}^ in order to define allelic profiles and STs.

Statistical Analyses
--------------------

In order to determine if the differences in the prevalence of staphylococcal species and isolates harboring ACME were significant between different sample sites or patient groups, two-tailed Fisher's exact tests were utilized. These analyses were carried out using GraphPad QuickCalcs^[5](#fn05){ref-type="fn"}^. A *P* value of \<0.05 was deemed statistically significant. Statistical power analyses were calculated using the DSS research statistical power calculator tool^[6](#fn06){ref-type="fn"}^ with a confidence interval of 5%.

Nucleotide Accession Numbers
----------------------------

The Genbank database accession numbers for the nucleotide sequences of the *S. epidermidis* ACMEs previously characterized ([@B28]; [@B33]) and in the present study are listed in **Table [1](#T1){ref-type="table"}**.

Results
=======

Prevalence of *S. epidermidis* and *S. aureus* in the Oral Cavity
-----------------------------------------------------------------

*Staphylococcus epidermidis* was recovered from the oral rinse samples of 18/20 (90%) patients with periodontal disease, 18/38 (47.4%) patients with peri-implantitis, 25/31 (80.6%) orally healthy patients with implants and 44/64 (68.8%) orally healthy participants (**Table [2](#T2){ref-type="table"}**). *Staphylococcus epidermidis* was significantly more prevalent in the oral rinse samples of orally healthy patients with implants than in those with peri-implantitis (*P* = 0.0061, Power = 90%), however the difference in the prevalence of *S. epidermidis* in the oral rinse samples of patients with periodontal disease in comparison to orally healthy participants was not quite statistically significant (*P* = 0.081).

###### 

Prevalence of ACME types harbored by *S. epidermidis* from distinct patient groups and anatomical sites.

  Patients (*n*)                 Sample site   Prevalence of *S. epidermidis* per patient (%)   Prevalence of *S. aureus* per patient (%)   Number of isolates harboring ACME (%)   Prevalence of *S. epidermidis* harboring ACME (%)   ACME types identified among *S. epidermidis* (*n* = patients)                            
  ------------------------------ ------------- ------------------------------------------------ ------------------------------------------- --------------------------------------- --------------------------------------------------- --------------------------------------------------------------- ---- --- --- --- --- --- ---
  Periodontal disease (20)^a^    OR            18/20 (90)                                       5/20 (25)                                   14/27 (51.9)                            12/20 (60)                                          2                                                               5    1   3   0   0   1   0
                                 PP            6/20 (30)^3^                                     0/20 (0)                                    6/9 (66.7)                              5/20 (25)^7^                                        0                                                               3    0   1   0   1   0   0
                                 SG            4/20 (20)                                        0/20 (0)                                    5/6 (83.3)                              4/20 (20)                                           1                                                               3    0   0   0   0   0   0
  Peri-implantitis (29, 38)^b^   OR            18/38 (47.4)^1^                                  8/38 (21.1)^2^                              4/15 (26.7)                             4/38^c^ (10.5)                                      0                                                               3    1   0   0   0   0   0
                                 SG            15/29 (51.7)^4^                                  3/29 (10.3)                                 13/19 (68.4)                            11/29 (37.9)^6,8^                                   0                                                               8    1   1   1   0   0   0
  Healthy with implants (31)     OR            25/31 (80.6)^1^                                  15/31 (48.4)^2^                             24/39 (61.5)                            19/31 (61.3)^5^                                     3                                                               8    2   3   0   3   0   0
                                 SG            5/31 (16.1)                                      4/31 (12.9)                                 5/9 (55.6)                              4/31 (12.9)^8^                                      1                                                               0    1   1   0   0   0   1
  Orally healthy (64)            OR            44/64 (68.8)                                     19/64 (29.7)                                26/50 (52)                              23/64 (35.9)^5^                                     2                                                               15   1   3   0   0   2   0
                                 SG            5/64 (7.8)^3,4^                                  5/64 (7.8)                                  3/5 (60)                                3/64 (4.7)^6,7^                                     0                                                               1    0   2   0   0   0   0

Significant differences in the prevalence of

S. epidermidis

between paired sample types from distinct patient groups are indicated by identical numerals in superscript.

a

Subgingival samples were taken from patients with periodontal disease prior to any dental treatment.

b

Oral rinse samples were recovered from 38 patients with peri-implantitis; subgingival samples were taken from 29 of these patients.

c

Isolates recovered from oral rinse samples of four patients could not be located to be screened for the presence of ACME and thus were not included in statistical analyses. OR, oral rinse; SG, subgingival site; PP, periodontal pocket.

The prevalence of *S. aureus* was considerably lower than *S. epidermidis* among all four groups of participants examined, detected in 5/20 (25%) patients with periodontal disease, 8/38 (21.1%) patients with peri-implantitis, 15/31 (48.4%) orally healthy patients with implants and 19/64 (29.7%) of orally healthy participants (**Table [2](#T2){ref-type="table"}**). The prevalence of *S. aureus* was highest in the oral cavities of healthy patients with oral implants and was significantly more prevalent in the oral rinse samples of this patient group when compared to the corresponding sample sets from patients with peri-implantitis (*P* = 0.0219, Power = 77.8%).

Prevalence of *S. epidermidis* and *S. aureus* in Subgingival Sites, Peri-implant Sites and Periodontal Pockets
---------------------------------------------------------------------------------------------------------------

*Staphylococcus epidermidis* was recovered from the periodontal pockets of 6/20 (30%) patients with periodontal disease and the peri-implant sites of 15/29 (51.7%) patients with peri-implantitis. In contrast*, S. epidermidis* was only recovered from the subgingival sites of 5/31 (16.1%) orally healthy patients with implants and 5/64 (7.8%) of orally healthy participants (**Table [2](#T2){ref-type="table"}**). *Staphylococcus epidermidis* was significantly more prevalent in the periodontal pockets of patients with periodontal disease than the subgingival sites of orally healthy participants (*P =* 0.0189, Power = 77.1%). Similarly, the prevalence of *S. epidermidis* was significantly higher in the subgingival sites of patients with peri-implantitis than similar sites in orally healthy patients with implants (*P =* 0.0057, Power = 91.4%).

*Staphylococcus aureus* was equally or less prevalent than *S. epidermidis* in the subgingival sites of all participant groups investigated, recovered from none of the periodontal pockets of patients with periodontal disease, 3/29 (10.3%) peri-implant pockets of patients with peri-implantitis, 4/31 (12.9%) of orally healthy patients with implants and 5/64 (7.8%) of orally healthy participants (**Table [2](#T2){ref-type="table"}**). The prevalence of subgingival *S. aureus* was not significantly different in any of the four participant groups investigated.

Prevalence of ACME Among *S. epidermidis* and *S. aureus* Isolates Recovered
----------------------------------------------------------------------------

The Arginine catabolic mobile element was detected in 100/179 (55.9%) of the *S. epidermidis* isolates recovered from all four participant groups (**Table [2](#T2){ref-type="table"}**). The *mecA* gene was detected in 12/179 (6.7%) isolates; two from patients with periodontal disease, three from patients with peri-implantitis, three from orally healthy patients with implants and four from orally healthy participants. In total, 5/12 of the MRSE isolates identified also harbored ACMEs, predominantly type II.

Among the samples from which *S. epidermidis* was recovered, ACME was detected in isolates recovered from the oral rinse samples of 12/20 (60%) patients with periodontal disease, 4/38 (10.5%) patients with peri-implantitis, 19/31 (61.3%) orally healthy patients with implants, and 23/64 (35.9%) orally healthy participants. The prevalence of *S. epidermidis* isolates harboring ACME was significantly higher in the oral rinse samples of orally healthy patients with implants than in those of healthy participants (*P* = 0.0275, Power = 76.1%).

Although the prevalence of *S. epidermidis* was lower in subgingival sites than in the oral rinse samples of all four participant groups, the proportion of ACME-harboring *S. epidermidis* isolates was higher (**Table [2](#T2){ref-type="table"}**). The presence of ACME was detected in *S. epidermidis* isolates from the periodontal pockets and subgingival sites of 5/20 (25%) and 4/20 (20%) patients with periodontal disease, respectively. Similarly, ACME was detected in 11/29 (37.9%), 4/31 (12.9%) and 3/64 (4.7%) *S. epidermidis* isolates from the subgingival sites of patients with peri-implantitis, healthy patients with dental implants and orally healthy participants, respectively.

Isolates harboring ACME were significantly more prevalent in subgingival samples of patients with peri-implantitis than in subgingival samples of orally healthy participants (*P* = 0.0001, Power = 98.4%). Similarly, isolates with ACME were also significantly more prevalent in periodontal pockets of patients with periodontal disease than subgingival sites of orally healthy participants (*P* = 0.0167, Power = 78.5%). Interestingly, the prevalence of ACME-harboring isolates was also significantly higher in the subgingival sites of patients with peri-implantitis than subgingival sites of orally healthy patients with implants (*P* = 0.0369, Power = 72.9%).

In contrast, ACME was not detected in any of the 83 *S. aureus* isolates recovered from oral rinse samples (*n* = 56) and subgingival samples (*n* = 27) investigated.

All five previously described ACME types were detected in *S. epidermidis* isolates in the present investigation by multiplex PCR. In all participant groups and anatomical sites sampled, ACME type II was the predominant ACME type, identified in *S. epidermidis* isolates recovered from 53 of the participants investigated. The recently described ACME types IV and V were detected in *S. epidermidis* isolates recovered from 15 and one participants sampled, respectively (**Table [2](#T2){ref-type="table"}**).

Pairs of separate *S. epidermidis* isolates recovered from the oral rinse and subgingival samples of four orally healthy patients with implants were found to harbor distinct ACME types (i.e., types I and II or types I and IV). Similarly, a pair of *S. epidermidis* isolates recovered the same periodontal pocket of a patient with periodontal disease harbored ACME types I and II, respectively (**Table [2](#T2){ref-type="table"}**). Furthermore, pairs of separate *S. epidermidis* isolates harboring ACMEs II and III were detected in the same oral rinse sample of one patient with periodontal disease and in two orally healthy participants.

A total of 35 *S. epidermidis* isolates selected as representatives of each ACME type, patient group, sample site and ACME type were subjected to WGS in order to elucidate the genetic organization of the ACMEs harbored in detail (**Table [1](#T1){ref-type="table"}**).

Genetic Diversity of ACME Type I
--------------------------------

Two isolates recovered from the oral rinse samples of a patient with periodontal disease (P14OR1) and an orally healthy patient with implants (I12OR1) were found to harbor ACME type I by multiplex PCR and were subjected to WGS. The STs of these isolates were identified as ST17 and ST7, respectively (**Table [1](#T1){ref-type="table"}**). These STs are double locus variants of each other, differing at the *gtr* and *pyrR* loci by a total of four bp.

In both isolates, the ACME type I element was collocated with additional modules in CIs that were 54.3 and 39.9 kb in size, respectively (**Figure [1](#F1){ref-type="fig"}**). Both of the ACME type I elements characterized harbored the *arc* and *opp3* operons, the *speG* gene and were demarcated by DRs_B and \_C (**Table [3](#T3){ref-type="table"}**). In both isolates, ACME type I was located directly downstream of a module composed of the *copA* gene and the *ars* operon, separated by DR_B. In isolate I12OR1, this module was demarcated by an additional DR_B at the 5′ end in *orfX*, whereas in isolate P14OR1 this module was demarcated by DR_O at the 5′ end and an additional module containing three ORFs was located upstream of the *copA/ars* operon module (**Figure [1](#F1){ref-type="fig"}**).

![Schematic representation of ACME type I elements harbored by two distinct *S. epidermidis* isolates investigated by WGS. The ACME type I previously described in the MRSA reference USA300 strain FPR3757 (Genbank accession number [CP000255.1](CP000255.1)) is included for comparison **(A)**. The size of each ACME is indicated after each strain name. **(B,C)** Each gene or group of genes of interest is differentiated by a different color, i.e., light blue; *opp3*-operon, red; *arc*-operon, pale green; *cop*-operon, yellow; *ars* operon, dark blue; *ccrAB* complexes, dark green; *pbp2a*, dark gray; *speG*, light gray; genes encoding hypothetical proteins, sugar transporters, transposases and other ORFs, previously identified in ACMEs. The direction of transcription for each ORF is indicated by arrows. The DRs are indicated in bold font and correspond to DR sequences listed in **Table [3](#T3){ref-type="table"}**.](fmicb-09-01558-g001){#F1}

###### 

Direct repeat sequences (DRs) identified among ACME types investigated.

  DR     Sequence (5′-3′)     Associated ACME types/subtypes and CIs
  ------ -------------------- ----------------------------------------
  DR_A   GAAGCATATCATAAATGA   IIa, IIb, IIc, IVa, V
  DR_B   GAAGCGTATCACAAATAA   I, IIa, III^a^, IVa, V
  DR_C   GAAGCGTATCGTAAGTGA   I, IIa, IIb, III^a^, IVa, IVb, V
  DR_D   GAAGCGTACCACAAATAA   IIa, IIb,
  DR_E   GAAGCGTATTAAAGTGAT   IIc
  DR_F   GAAAGTTATCATAAGTGA   IVb, V
  DR_G   GAAGCGTATAATAAGTAA   IIa, IIb, III^a^, IVa, IVb, V
  DR_H   GAAGCGTATCATAAGTGA   IIa
  DR_I   GAAGCGTATCATAAATGA   I
  DR_J   GAGGCGTATCATAAGTAA   I
  DR_L   GAAGCATATCATAAGTGA   IIa, III^a^, V
  DR_M   GAAGGGTATCATAAATAA   III^a^
  DR_N   GAAGCGTATCACAAATGA   IVa
  DR_O   GAAGCATATCATAAATAA   I
  DR_P   GAAGCTTATCATAAATGA   I
                              

a

The DRs \_B, \_L, \_M, \_G and \_C described in the present study correspond to the DR1_A, DR_1B, DR_2, DR_3 and DR_4 previously described in ACME type III structures (

McManus et al., 2017

).

Genetic Diversity of ACME Type II
---------------------------------

Seventeen isolates harboring ACME type II were identified by multiplex PCR and were further investigated by WGS (**Figure [2](#F2){ref-type="fig"}**). All 17 isolates harbored ACMEs with the *arc* operon only and lacked both the *opp3* and *kdp* operons. Based on the differing combinations of DRs identified at the 5′ and 3′ ends, the ACME type II elements characterized could be divided into three distinct subtypes (IIa-c) of which ACME type IIb predominated (12/17, 70.6%). ACME type IIa was demarcated by the DRs \_H and \_C (**Table [3](#T3){ref-type="table"}**) and was identified in 3/17 isolates (**Figures [2B--D](#F2){ref-type="fig"}**), all of which belonged to ST59. ACME type IIb (**Figures [2E--I](#F2){ref-type="fig"}**) was demarcated by the DRs \_D and \_C and was identified in 12/17 isolates belonging to ST89 (*n* = 1), ST14 (*n* = 2), ST73 (*n* = 8) and ST701, a single locus variant of ST73 (*n* = 1). The remaining two isolates harbored ACME type IIc demarcated by the DRs \_A and \_E and belonged to ST672 (**Figures [2J,K](#F2){ref-type="fig"}**). Interestingly in the case of the latter two isolates, the *copA* and *ars* operon were internalized within ACME type IIc in both isolates (**Figures [2J,K](#F2){ref-type="fig"}**) and both lacked the internal DR_G commonly identified downstream of the *arc* operon in ACME type II. The ACME type IIc-harboring CIs in these isolates were almost identical, differing only by the presence of an ORF upstream of the *sdrH* gene in isolate P14PPP2 (**Figure [2K](#F2){ref-type="fig"}**).

![Schematic representation of ACME II subtypes a-c and ACME type II-harboring CIs investigated in the present study. The previously described ACME type II CI harbored by the *S. epidermidis* reference strain ATCC12228 (Genbank accession number [AE015929](AE015929)) is included for reference **(A)**. The size of each ACME is shown after the strain name. Each gene or group of genes of interest is differentiated by a different color, i.e., red; *arc*-operon, pale green; mustard; *tetR*, *cop*-operon, yellow; *ars* operon, dark blue; *ccrAB* genes, dark green; *mecA*, dark gray; *speG*, light gray; genes encoding hypothetical proteins, sugar transporters, transposases and other ORFs, previously identified in ACMEs. The direction of transcription for each ORF is indicated by the arrow. The DRs are indicated in bold font and correspond to each DR sequence listed in **Table [3](#T3){ref-type="table"}**.](fmicb-09-01558-g002){#F2}

Five of the 17 ACME type II structures characterized by WGS existed as modules of larger CIs and were collocated with modules which harbored genes associated with SCC elements such as *ccr* and *mec* (**Figures [2B,C,I--K](#F2){ref-type="fig"}**). In each of these five CIs, the ACME type II structure was divided from these SCC-associated modules by DRs \_A, \_H, or \_D (**Table [3](#T3){ref-type="table"}**).

Interestingly, in one isolate (217PPP362) two separate and distinct SCC-associated modules were detected in tandem upstream of ACME type IIa (**Figure [2C](#F2){ref-type="fig"}**). The module immediately upstream of ACME type IIa was demarcated by the DRs \_L and \_H and harbored the *speG* and *ccrAB4* genes and was collocated immediately downstream of an additional SCC-associated module which harbored the *mecA* and *ccrAB2* genes. The ACME type IIa and IIb structures in the remaining 12/17 isolates investigated had integrated directly into *orfX* in the absence of any adjacent modules and were not components of larger CIs (**Figure [2](#F2){ref-type="fig"}**).

The presence of *sdr* genes, members of the serine/aspartate repeat family encoding fibrinogen-binding proteins was detected in modules adjacent to ACME type II in 3/17 isolates investigated and was collocated with ACME subtype IIb and IIc identified in the present study.

The *speG* gene encoding spermidine acetyltransferase was detected in only one isolate harboring ACME type II, (217PPP362) located in a SCC-associated module upstream of ACME type IIa (**Figure [2C](#F2){ref-type="fig"}**). The *copA* gene was located near the 3′ end of all 17 ACME type II structures investigated. In all ACME type IIa and IIb structures investigated, this gene was separated from the *arc* operon by DR_G and additional open reading frames commonly identified within ACMEs (**Figure [2](#F2){ref-type="fig"}**).

Genetic Diversity of ACME Type III
----------------------------------

Four isolates harbored ACME type III, all of which were identified as ST329 (**Table [1](#T1){ref-type="table"}**). Three of the ST329 isolates (P16OR1, 204OR1 and I11OR1) have been described previously ([@B28]). The CI harbored by the fourth isolate (I1PPP121) consisted of two distinct modules separated by DR_G (**Figure [3](#F3){ref-type="fig"}**). The module at the 5′ end harbored two pairs of *ccr* genes, of which *ccrA4* and *ccrB2* were prematurely truncated. This module also harbored the *copA* and *ars* genes, located upstream of ACME type III as previously observed in the other three isolates. The ACME type III harbored by I1PPP121 exhibited a minimum of 99.81% nucleotide identity to the ACME type IIIs harbored by isolates P16OR1, 204OR1, and I11OR1.

![Schematic representation of ACME type III structure from oral *S. epidermidis* isolate I1PPP121 characterized in the present study. The previously described ACME type III structure from an *S. epidermidis* isolate (P16OR1) recovered from an oral rinse sample from a patient with periodontal disease ([@B28]) is included for comparison **(A)**. The size of the ACME characterized is shown after the isolate name I1PPP121 **(B)**. Each gene or group of genes of interest is differentiated by a different color, i.e., pale green; *cop*-operon, dark blue; *ccrAB* gene complexes (of which the genes *ccrA4* and *ccrB2* were prematurely truncated), light blue; *opp3* operon, dark green; *pbp4*, light gray; genes encoding hypothetical proteins, sugar transporters, transposases and other ORFs, previously identified in ACMEs. The direction of transcription for each ORF is indicated by the arrow. The DRs are indicated in bold font and correspond to each DR sequence listed in **Table [3](#T3){ref-type="table"}**.](fmicb-09-01558-g003){#F3}

Genetic Diversity of ACME Types IV and V
----------------------------------------

Eleven isolates harboring ACME type IV were identified and belonged to ST210 (*n* = 1), ST153 (*n* = 6), ST130 (*n* = 1), ST17 (*n* = 1), ST297 (*n* = 1), and ST432 (*n* = 1) (**Table [1](#T1){ref-type="table"}**). Nine of these isolates were described recently in a study that first defined ACME types IV and V in *S. epidermidis* ([@B33]). The two additional ST153 isolates (PS7P2 and PS23P1) were characterized in the present study and harbored ACME types IVa and IVb, respectively. The ACME type IVa harbored by isolate PS7P2 was identical to those previously described in isolates 120PPC, I9OR1 and I14OR1, and the ACME type IVb harbored by isolate PS23P1 was identical to that previously described in isolate P8OR3 ([@B33]). ACME type V was identified in only one isolate, recovered from the subgingival site of a patient with peri-implantitis and has been previously described ([@B33]).

Genetic Diversity Among the *arc*, *opp3* and *kdp* Operons Harbored by ACME Types I--V
---------------------------------------------------------------------------------------

### The *arc* Operon

The percentage nucleotide identity between all ACME-*arc* operons identified in the present study, in ACME types I, II, IV and V ranged from 99.06 to 100%. The ACME-*arc* operons harbored by isolates 200OR2, 32BR, PS7OR and PS8TI (all ACME type IIb) exhibited 100% nucleotide identity to each other, as did that harbored by isolates 120PPC, I9OR1, I14OR1 (all ACME type IVa). Similarly, the ACME-*arc* operon harbored by P9OR1, P9PPH12, P9PPHI1, P11OR1 and P11PPH21 (all ACME type IIb) exhibited 100% nucleotide identity with each other (Supplementary Table [2](#SM1){ref-type="supplementary-material"}).

### The *opp3* Operon

The percentage nucleotide identity between all *opp3*-operons identified in the present study, in ACME types I, III and V ranged from 97.22 to 100% (Supplementary Table [S3](#SM1){ref-type="supplementary-material"}). The *opp3* operon harbored by isolates P16OR1 and P11OR1 (both ACME type III) exhibited 100% nucleotide identity to each other. The *opp3* operons harbored by ACME type I exhibited 99.91% to each other and 99.96% nucleotide homology to the *opp3* operon harbored by the reference ACME type I (Genbank accession number [CP000255.1](CP000255.1)). The *opp3* operon harbored by the recently described ACME type V ([@B33]) exhibited 99.22-99.24% and 97.48--97.52% nucleotide identity to those harbored by ACME types III and I, respectively (Supplementary Table [S3](#SM1){ref-type="supplementary-material"}).

### The *kdp* Operon

The *kdp* operon was highly conserved, exhibiting a minimum of 99.86% nucleotide identity amongst isolates harboring ACME types IV and V. The *kdp* operons harbored by isolates 120PPC, PS30PH, 33BR, 218PP361, PS7P2 and I9OR1 (all ACME type IVa) exhibited 100% nucleotide identity to each other, and to that harbored by PS23P1 (ACME type IVb). The *kdp* operon harbored by the remaining ACME type IVb isolates, PS36PD and P8OR3 exhibited 99.94% nucleotide identity to each other. The *kdp* operon harbored by ACME type V exhibited a minimum of 99.86% nucleotide identity to the *kdp* operon harbored by ACME types IVa and IVb (Supplementary Table [S4](#SM1){ref-type="supplementary-material"}).

Comparison of ACMEs Among Multiple *S. epidermidis* Isolates From the Same Patients
-----------------------------------------------------------------------------------

Three isolates recovered from the periodontal pockets and oral rinse sample of a patient with periodontal disease (P9) were all identified as ST73 (**Table [1](#T1){ref-type="table"}**) and harbored genetically identical ACME type IIb structures (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). In contrast, three distinct *S. epidermidis* isolates recovered from the oral rinse, nasal swab and periodontal pocket of a patient (P14) with periodontal disease were identified as STs 17, 14 and 672, and harbored ACME types I, IIb and IIc, respectively (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). Similarly, an isolate identified as ST59 and harboring ACME type IIa was recovered from the periodontal pocket of a patient with periodontal disease (P11) and was genetically distinct to two other isolates identified as ST73 and harboring ACME type IIb which were recovered from the oral rinse and another periodontal pocket of the same patient.

Discussion
==========

The Prevalence of Staphylococci in the Oral Cavity, Subgingival Sites and Periodontal Pockets
---------------------------------------------------------------------------------------------

Previous investigations of the prevalence of staphylococcal species in the oral cavity are conflicting and/or ambiguous for several probable reasons. Firstly, studies did not definitively distinguish between distinct CoNS species and *S. aureus* ([@B23]). Secondly, different studies used semi-discriminatory agar media such as Baird Parker or MSA for primary recovery, which may have resulted in failure to select and further distinguish between morphologically similar colonies of distinct CoNS species ([@B26]; [@B8]; [@B11]). Thirdly, several previous studies relied on checkerboard DNA-DNA hybridization techniques for definitive identification of oral staphylococcal species from patients with dental implants, an approach that does not distinguish between viable and dead bacteria ([@B15]; [@B40]; [@B43]). Subsequently, real-time PCR with species-specific primers demonstrated that the previously used DNA:DNA hybridization probes showed cross reactivity between *S. aureus* and *S. epidermidis* DNA ([@B7]).

Patient sampling and recovery of viable isolates was undertaken using a uniform, systematic methodology for all sample sites and patient groups and identification of both *S. epidermidis* and *S. aureus* isolates was determined using robust procedures. The utilization of the chromogenic Sa*Select*^TM^ medium for primary isolation of oral staphylococci enabled direct visualization and presumptive identification of both *S. epidermidis* and *S. aureus* isolates based on the growth of these species as white/pale pink and pink colonies, respectively. This approach ensured that the differences in the prevalence of *S. epidermidis* and *S. aureus* observed are a true reflection of the patient groups and sample sites investigated.

### Staphylococcus epidermidis

*Staphylococcus epidermidis* was detected in the oral cavities of 47.4 -- 90% of the four participant groups investigated (**Table [2](#T2){ref-type="table"}**) which was higher than previous studies that reported its recovery from the oral cavities of 27.3% patients with periodontal disease ([@B26]) and 41% of orally healthy participants ([@B34]).

Previous reports of the prevalence of subgingival *S. epidermidis* vary greatly, ranging between 15.9 and 64.3% in periodontal pockets ([@B26]; [@B31]; [@B11]) and between 42.9 and 60.7% in the subgingival sites of healthy participants ([@B31]; [@B34]), most likely due to different methods used. Data on the subgingival prevalence of *S. epidermidis* in patients with oral implants and/or peri-implantitis are largely lacking or did not undertake definitive identification of this species ([@B23]).

### *Staphylococcus aureu*s

In the present study, *S. aureus* was considerably less prevalent than *S. epidermidis* in the oral cavities of participant groups and was rarely detected in subgingival sites or periodontal pockets (**Table [2](#T2){ref-type="table"}**). The dramatic contrast in the oral prevalence of *S. epidermidis* and *S. aureus* was not surprising, as a negative correlation between the prevalence of these species has been reported previously ([@B6]). Previous reports of the prevalence of subgingival *S. aureus* vary greatly, ranging from 13.4 to 68.2% ([@B8]; [@B57]) in periodontal pockets, 40--70.4% of peri-implant pockets and 25--44% of healthy subgingival sites around dental implants ([@B15]; [@B40]; [@B43]). The contrasting results between the present and previous studies most likely reflects differences in methodology used as discussed above.

The Prevalence of ACME in *S. epidermidis* and *S. aureus*
----------------------------------------------------------

The prevalence of ACME has previously been investigated amongst *S. epidermidis* populations and has been reported to range from 40 to 65.4% in MRSE, and from 64.4 to 83% in methicillin susceptible *S. epidermidis* ([@B29]; [@B3]; [@B12]; [@B35]). In the present investigation, only 12/179 (6.7%) of the *S. epidermidis* isolates recovered were MRSE. This finding correlates with previous studies that reported a higher prevalence of ACME in methicillin-susceptible *S. epidermidis*. Five of the 12 MRSE isolates identified here harbored ACMEs, predominantly ACME type II.

This is the first investigation into the prevalence of ACME amongst *S. epidermidis* and *S. aureus* isolates recovered from both above and below the gumline in patients with and without oral disease. The prevalence of ACME was greater than 50% amongst the populations of *S. epidermidis* recovered. In contrast, ACME was not detected in any of the *S. aureus* isolates recovered.

This study revealed for the first time that the prevalence of ACME-harboring *S. epidermidis* was significantly higher in subgingival sites of patients with peri-implantitis and periodontal disease in comparison to healthy individuals (*P* = 0.0001 and *P* = 0.0167, respectively). Furthermore, *S. epidermidis* harboring ACME were significantly more prevalent in the subgingival sites of patients with peri-implantitis than in orally healthy patients with implants. Together, these results suggest a strong association of *S. epidermidis* isolates harboring ACME with diseased, semi-anaerobic subgingival tissue sites. No correlation between specific ACME types or subtypes and specific disease state or oral site was identified.

One of the potential limitations of the present investigation was the number of patients sampled. The study group was limited to patients attending DDUH who did not have any underlying conditions and had not received antibiotics in the 2 months prior to sampling. It is likely that larger investigations would further support the findings of this study as well as likely identify additional ACME types. Furthermore, it would be interesting to determine if ACME is more abundant in *S. epidermidis* isolates recovered from other diseased anatomical sites or wounds.

The Genetic Diversity of ACME
-----------------------------

Previous investigations of the prevalence and structural diversity of ACME relied on primers targeting the ACME-*arc* and ACME-*opp3* genes to detect ACME types I-III only ([@B29]; [@B35]). This study is the first to include primers targeting the recently described ACME-*kdp* operon in a multiplex ACME-typing PCR and therefore the results of this study accurately reflect the true prevalence of ACME types currently described in *S. epidermidis*, at least of oral origin. The application of WGS to the characterization of ACME has revealed the additional ACME types harbored by *S. epidermidis* in addition to the detailed structural diversity of these ACMEs. It is highly likely that *S. epidermidis* isolates harboring the *opp3* and *kdp* operons and the *kdp* operon only will also be identified in the future using WGS.

Common DRs were often observed amongst multiple ACME types and subtypes (**Table [3](#T3){ref-type="table"}**). Many distinct DRs have been identified at the 5′ end of ACME, which is clearly demarcated by the integration of this element into *orfX*. The demarcation of the 3′ end is less obvious. Previously described ACMEs terminated at the 3′ end by DR_J in ACME type I of *S. aureus* (Genbank accession number [CP000255.1](CP000255.1)) ([@B9]) and by DR_C in ACME types II-V of *S. epidermidis* ([@B16]; [@B28]; [@B33]), even though an internal DR_G is present downstream of the *arc* operon in both the reference ACME type II (Genbank accession number [AE015929](AE015929)) and subsequently described in ACME types II (**Figure [2](#F2){ref-type="fig"}**) and IV ([@B33]). Many of the ACMEs characterized in the present and previous studies were components of CIs that were separated by multiple DRs, and greatly contributed to the diversity of these MGEs. Interestingly, the *copA* gene and *ars* operon were commonly detected in various distinct positions within or adjacent to ACME types I, II, III, and V. These genes were identified downstream of the ACME type II element in several isolates investigated in the present study (data not shown) but were internalized within the ACME type IIc structures (**Figure [2](#F2){ref-type="fig"}**). The identification of multiple DRs in common amongst distinct ACME types and the frequent organizational differences observed both within and between each ACME type supports previous studies that suggested ACMEs are assembled in a stepwise, modular fashion ([@B52]). Indeed, ACME diversity was also observed among separate isolates recovered from the oral cavities of the same patient (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}) in three cases.

The Association of ACME With Specific *S. epidermidis* Lineages
---------------------------------------------------------------

Isolates harboring ACME type I investigated here were identified as STs 7 and 17 (**Table [1](#T1){ref-type="table"}**), both of which have been previously assigned to GC6 by Bayesian clustering analysis ([@B51]; [@B54]), a GC that is enriched with ACME-harboring isolates and associated with infection sources. Isolates harboring ACME type II were identified as STs 73 (and ST701, a single locus variant of ST73), 59, 89, 14, and 672, four of which have previously been assigned to GC1, a GC enriched with isolates from non-hospital sources ([@B51]; [@B54]). Two isolates harboring ACME type IIc from periodontal pockets of two separate patients were identified as ST672, however, this ST was not previously assigned to a GC. All isolates harboring ACME type III were recovered from separate patients and all belonged to ST329, previously associated with GC4. Isolates belonging to GC4 have been associated with a more commensal lifestyle ([@B51]). Isolates harboring ACME type IV were identified as STs 153, 297, 130, and 17, of which four were previously assigned to GC6. The isolate harboring ACME type V, identified as ST5, also belonged to GC6.

Distinct ACME types were more commonly associated with isolates belonging to identical or closely related STs, rather than the participant group or sample sites from which each ACME-harboring isolate was recovered. Indeed, many STs identified amongst isolates recovered from the oral rinse samples of healthy participants belonged to GC6 (**Table [2](#T2){ref-type="table"}**), a cluster enriched with isolates from infections ([@B54]). These findings strongly suggest that the stepwise accumulation of ACMEs occurs in specific lineages of *S. epidermidis*, rather than in specific anatomical sites.

The Potential Role of ACME in Disease
-------------------------------------

In the present study, the predominant ACME types detected (II and IV) in *S. epidermidis* harbored the *arc* operon. Researchers have hypothesized that ACME enhances the transmissibility, colonization and persistence of the MRSA USA300 strain on human skin, contributing to the success of this lineage ([@B10]; [@B38]). The arginine deaminase pathway encoded by *arc* is responsible for the breakdown of polyamines which are largely [L]{.smallcaps}-arginine based. This results in the formation of ornithine, ATP, CO~2~ and ammonia, the latter of which contributes to the internal pH regulation of staphylococci in acidic conditions ([@B38]; [@B25]). The contribution of the constitutively expressed *arc* operon is likely to be highly advantageous to staphylococcal survival in the acidic environments present in dental plaque. In addition, the ATP generated is likely beneficial to organisms living in nutrient poor, semi-anaerobic environments such as present in periodontal pockets. Polyamines are associated with biological processes such as wound healing and infection clearance and it is therefore likely that they would be highly associated with oral inflammatory diseases such as periodontal disease and peri-implantitis. The *speG* gene, encoding a spermidine acetyltransferase, is thought to mitigate the lethal effects of polyamines on staphylococci. The exact benefit of the *opp3* operon is unclear but encodes an oligopeptide permease ABC transporter ([@B9], [@B10]). The *speG* gene and *opp3* operon were detected in only eight and seven of the 35 ACMEs characterized, respectively, suggesting that these genes are relatively dispensable for *S. epidermidis* in oral environments ([@B28]; [@B33]).

Interestingly, the *kdp* operon was detected in 12 of the 35 ACMEs characterized by WGS, suggesting that these genes contribute to the survival of *S. epidermidis* in oral environments. This operon encodes a potassium transporter that is important for maintaining intracellular pH homeostasis and metabolic processes in *S. aureus* ([@B39]) and likely plays an important role in the adaptation and survival of *S. epidermidis* in dental plaque, which has a significant concentration of K^+^ ions ([@B27]).

Conclusion
==========

This study revealed the significantly high prevalence of *S. epidermidis* in periodontal pockets and subgingival sites of patients with periodontal disease or peri-implantitis, respectively. There was also a very significant difference in the prevalence of *S. epidermidis* harboring ACME in these diseased subgingival sites and periodontal pockets compared to those recovered from healthy subgingival sites and oral rinse samples (**Table [2](#T2){ref-type="table"}**). As yet, it is unclear if this organism contributes to disease progression directly. The presence of five main ACME types among oral *S. epidermidis* isolates was identified and extensive genetic diversity among these types was revealed using WGS, which would have been overlooked using previously described multiplex PCRs ([@B29]; [@B35]). The *arc* and *kdp* operons harbored by the predominant ACME types identified (II and IV) very likely contribute to the survival of oral *S. epidermidis* under diseased and inflammatory conditions such as periodontal disease and peri-implantitis.
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